KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Times Interest Earned (2009 - 2012)

Eli Lilly posted quarterly Times Interest Earned of $31.02 for Q1 2012, down 15.09% year-on-year from $36.53 in Q2 2011, and up 45.42% on a QoQ basis from $21.33 in Q4 2011.

Eli Lilly (LLY) has 4 years of Times Interest Earned data on file, last reported at $31.02 in Q1 2012.

  • For the quarter ending Q1 2012, Times Interest Earned fell 15.09% year-over-year to $31.02; the trailing twelve-month figure through Dec 2012 stood at $110.71 (up 248.05% YoY), and the FY2011 full-year result was $10.07, down 18.24% from the prior year.
  • Times Interest Earned for Q1 2012 stood at $31.02, up from $21.33 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $36.53 in Q1 2011 and bottomed at $21.33 in Q4 2011.
  • The 4-year median for Times Interest Earned is $33.57 (2010), against an average of $31.74.
  • The widest annual swing landed in 2010, when Times Interest Earned soared 44.78%; it then slumped 36.41% in 2011.
  • A 4-year view of Times Interest Earned shows it stood at $23.2 in 2009, then surged by 44.57% to $33.54 in 2010, then plunged by 36.41% to $21.33 in 2011, then soared by 45.42% to $31.02 in 2012.
  • The last three Times Interest Earned figures came in at $31.02 (Q1 2012), $21.33 (Q4 2011), and $35.24 (Q3 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 23.39
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 4.06
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 10.78
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2012 31.02
Dec 31, 2011 21.33
Sep 30, 2011 35.24
Jun 30, 2011 35.23
Mar 31, 2011 36.53
Dec 31, 2010 33.54
Sep 30, 2010 32.31
Jun 30, 2010 33.59
Mar 31, 2010 35.36
Jun 30, 2009 23.20